SMN-C3 vir hydrate Effect of dual tocolysis with

Effect of dual tocolysis with fenoterol and atosiban in human myometrium

Purpurogallin (100 µM

³²]heptatriaconta-1(35)

it was subsequently removed from the market in 2007 due to FDA concerns about possible adverse cardiovascular effects

SMN-C3 vir hydrate Effect of dual tocolysis withSMN C3 is an orally active SMN2 splicing modulator and has the potential to treat spinal muscular atrophy (SMA). Product information CAS Number: 1449597 34 5 Molecular Weight: 416. 52 Formula: C24H28N6O Chemical Name: 2 {4,6 dimethylpyrazolo[1,5 a]pyrazin 2 yl} 7 (1 ethylpiperidin 4 yl) 9 methyl 4H pyrido[1,2 a]pyrimidin 4 one Smiles: CCN1CCC(CC1)C1=CN2C(=O)C=C(N=C2C(C)=C1)C1C=C2C(C)=NC(C)=CN2N=1 InChiKey: ZACWYYKZMLGOTG UHFFFAOYSA N InChi: InChI=1S